Search
28/02/2023
Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia
Vargas-Poussou, R, Claverie-Martin, F, Prot-Bertoye, C, Carotti, V, van der Wijst, J, Perdomo-Ramirez, A, Fraga-Rodriguez, GM, Hureaux, M, Bos, C, Latta, F, Houillier, P, Hoenderop, JGJ, de Baaij, JHF. Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(3)DOI:10.1093/ndt/gfac182. PMID:35561741. IF:4.800(Q1/2D).
28/02/2023
Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study
Bundo, M, Vlacho, B, Llussa, J, Bobe, I, Aivar, M, Ciria, C, Martinez-Sanchez, A, Real, J, Mata-Cases, M, Cos, X, Doria, M, Viade, J, Franch-Nadal, J, Mauricio, D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1)DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2.500(Q1/3D).
27/02/2023
Last twenty-years activity of cardiovascular tissue banking in Barcelona
Castells-Sala C., Pérez M.L., Agustí E., Aiti A., Tarragona E., Navarro A., Tabera J., Farinas, O, Pomar J.L., Vilarrodona A.. Last twenty-years activity of cardiovascular tissue banking in Barcelona. CELL AND TISSUE BANKING. 2023; DOI:10.1007/s10561-022-10059-9. PMID:36849631. IF:1.400(Q4/9D).
27/02/2023
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
Chmielecki, J, Gray, JE, Cheng, Y, Ohe, Y, Imamura, F, Cho, BC, Lin, MC, Majem, M, Shah, R, Rukazenkov, Y, Todd, A, Markovets, A, Barrett, JC, Hartmaier, RJ, Ramalingam, SS. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-35961-y. PMID:36849494. IF:14.700(Q1/1D).